The path(ology) from reflux oesophagitis to Barrett oesophagus to oesophageal adenocarcinoma
Authors:
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Tobacco Smoking Increases the Risk of High-Grade Dysplasia and Cancer Among Patients With Barrett's EsophagusGastroenterology, 2012
- Epidemiology and Natural History of Intestinal Metaplasia of the Gastroesophageal Junction and Barrett's Esophagus: A Population-Based StudyAmerican Journal of Gastroenterology, 2011
- Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based StudyJNCI: Journal of the National Cancer Institute, 2011
- American Gastroenterological Association Technical Review on the Management of Barrett's EsophagusGastroenterology, 2011
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Nonadenomatous Dysplasia in Barrett EsophagusAmerican Journal of Surgical Pathology, 2009
- Health-Related Quality of Life in Patients With Barrett's Esophagus: A Systematic ReviewClinical Gastroenterology and Hepatology, 2009
- Metaplastic Esophageal Columnar Epithelium Without Goblet Cells Shows DNA Content Abnormalities Similar to Goblet Cell–Containing EpitheliumAmerican Journal of Gastroenterology, 2009
- TP53 and progression from Barrett’s metaplasia to oesophageal adenocarcinoma in a UK population cohortGut, 2006
- Preoperative staging of superficial esophageal carcinoma: comparison of an ultrasound probe and standard endoscopic ultrasonographyGastrointestinal Endoscopy, 1996